Bio-Rad Laboratories, Inc. BIO.B Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s investing cash flow?
- Bio-Rad Laboratories, Inc. (BIO.B) reported investing cash flow of -$93.2M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s investing cash flow changed year-over-year?
- Bio-Rad Laboratories, Inc.'s investing cash flow decreased by 3313.8% year-over-year, from $2.9M to -$93.2M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s investing cash flow has grown at a -30.2% compound annual growth rate (CAGR), from -$797.38M to -$189.7M.
- What does investing cash flow mean?
- This metric aggregates all cash inflows and outflows related to the acquisition and disposal of long-term assets and financial investments. It provides a comprehensive view of how a company is allocating capital toward growth and asset management. A negative value typically indicates that the company is investing heavily in its future capacity or financial portfolio.